Pacemaker, Artificial
8
2
2
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
Genetic Basis of Pacing-induced Cardiomyopathy
Remote Programming of Cardiac Implantable Electronic Device
Slew Rate As a Predictor for Optimal Lead Fixation
Prospective Köln Bonn Registry for the Extraction of Pacmaker and ICD Leads
Comparison Between Early and Late Mobilization After Cardiac Device Implantation
Morbidity, Mortality and Gender Differences in Patients With Pacemakers
Evaluate the Benefits of Pacemaker Follow-Up With Home-Monitoring
A Pilot Study on Pacemaker Interference From Peripheral Nerve Stimulator for Regional Anesthesia